BUND FINANCE › Stocks › IDXX
IDEXX Laboratories, Inc. (IDXX)
NASDAQ · Stock price, chart and technical analysis
Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed
Key stats
Quick technical read
- Price is +22.73% above its 50-day average.
- It is +21.95% above its 200-day average (long-term uptrend).
- It sits at 73% of its 52-week range (0% = low, 100% = high).
This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it
Fundamentals Annual
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | US$3.2B | US$3.4B | US$3.7B | US$3.9B | US$4.3B |
| Net income | US$744.8M | US$679.1M | US$845.0M | US$887.9M | US$1.1B |
| EPS (diluted) | 8.60 | 8.03 | 10.06 | 10.67 | 13.08 |
| Gross margin | 58.8% | 59.5% | 59.8% | 61.0% | 61.8% |
| Operating margin | 29.0% | 26.7% | 30.0% | 29.0% | 31.6% |
| Net margin | 23.2% | 20.2% | 23.1% | 22.8% | 24.6% |
| Free cash flow | US$636.0M | US$394.1M | US$772.9M | US$798.1M | US$1.1B |
| Total debt | US$1.0B | US$1.5B | US$1.1B | US$986.9M | US$1.1B |
| Cash | US$144.5M | US$112.5M | US$453.9M | US$288.3M | US$180.1M |
Compound annual growth: revenue 7.6% · net income 9.2% (4 years).
Valuation: today, its history and its sector
| Today | 5-year average | Sector median (Healthcare) | |
|---|---|---|---|
| P/E | 47.4x | 54.0x | 27.1x |
| EV / EBITDA | 33.4x | 38.4x | 16.5x |
| Operating margin | 32.3% | — | 3.6% |
| Net margin | 25.4% | — | -0.0% |
| Debt / equity | 0.98 | — | 0.58 |
Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and c…
Other stocks on BUND FINANCE
Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice